How is Peyronie’s disease diagnosed and managed in a 40‑70‑year‑old man with diabetes, hypertension, smoking history, and prior penile trauma?

Peyronie's Disease: Diagnosis and Management

Diagnostic Approach

Diagnose Peyronie's disease through a detailed sexual history documenting penile curvature, pain, interference with intercourse, and psychosocial distress, combined with physical examination of the genitalia to assess for palpable plaques in the flaccid penis. 1

Essential History Elements

• Onset and duration of symptoms, precipitating factors (though most patients don't recall specific trauma), changes over time, and prior treatments 1
• Pain characteristics: presence, severity (use visual analog scale), timing (with or without erection), and progression 1, 2
• Erectile function status: ability to achieve/maintain erections sufficient for intercourse, as this determines treatment eligibility 1, 2
• Psychosocial impact: 54% of men report relationship difficulties, with persistent depressive symptoms and sexual confidence issues 1, 3

Physical Examination

• Flaccid penis examination: stretch and palpate the penile shaft to identify plaques, document circumcision status and any anatomical anomalies 1
• Note: plaques are often not palpable in the flaccid state, particularly in early disease 1

Objective Assessment Before Treatment

Perform an in-office intracavernosal injection (ICI) test with or without duplex Doppler ultrasound prior to any invasive intervention. 1, 2

• ICI test enables: assessment of penile deformity, plaque location/size, pain in the erect state, and degree of curvature 1
• Duplex ultrasound adds: differentiation of calcified vs. non-calcified plaques, plaque measurements, and vascular integrity assessment 1

---

Disease Phase Classification

The critical first step is determining whether disease is active or stable, as this completely dictates treatment strategy. 3, 2

Active Phase Characteristics

• Defining feature: penile or glanular pain with or without erection 1, 3
• Dynamic symptoms: changing curvature, incompletely developed plaques, progressive deformity 1, 3, 2
• Duration: typically 3-12 months from symptom onset 2

Stable Phase Characteristics

• Defining feature: symptoms clinically unchanged for at least 3 months based on patient report or clinician documentation 1, 3
• Established findings: minimal or absent pain, fixed curvature (uniplanar or biplanar), palpable plaques on exam or ultrasound 1, 3
• Timing: disease typically stabilizes at 12-18 months after symptom onset 2

---

Management Algorithm

Active Phase Treatment

For pain management during active disease, offer oral NSAIDs as first-line therapy. 1, 3, 2

• Pain assessment: use visual analog scale and periodically reassess to measure treatment efficacy 1, 2
• Adjunctive therapy: consider daily tadalafil 5mg to reduce collagen deposition and decrease curvature progression 3, 2

Critical pitfall: Do NOT offer vitamin E, tamoxifen, procarbazine, omega-3 fatty acids, or vitamin E with L-carnitine—there is no convincing evidence for efficacy of any of these agents. 1

Avoid radiotherapy: provides no benefit over natural disease progression and exposes patients to unnecessary radiation risks 2

Extracorporeal shockwave therapy (ESWT) has low overall utility, as penile pain commonly resolves over time regardless of intervention 2

Stable Phase Treatment

For Mild Curvature

• Observation is appropriate, as many patients function adequately with mild deformity 2

For Moderate Curvature (30-90 degrees)

Intralesional collagenase clostridium histolyticum (Xiaflex) is the only FDA-approved non-surgical therapy for stable Peyronie's disease with moderate curvature and intact erectile function. 3, 2, 4

Treatment protocol: 2, 4

• Up to 4 treatment cycles with 2 injections per cycle (maximum 8 total injections over approximately 24 weeks)
• Each injection: 10,000 U (0.58 mg)
• Mandatory modeling exercises performed by clinician and patient after each injection cycle

Expected outcomes: 2, 4

• Mean curvature reduction of 17° versus 9.3° with placebo at one-year follow-up
• Improvement in patient-reported bother and sexual function

Critical limitations: 2, 4

• Requires palpable plaque on physical examination
• Treats curvature only—does NOT treat pain or erectile dysfunction
• Safety and efficacy of more than 8 total injections has not been established

Common adverse events: penile ecchymosis, swelling, and pain; rare serious events include corporal rupture and penile hematoma 4

Surgical Treatment

Surgery should only be considered when disease has been stable for at least 3 months and curvature compromises sexual function. 1, 2

Surgical candidacy criteria: 2

• PD symptoms present for at least 12 months
• Stable curvature for 3-6 months
• Curvature that prevents satisfactory intercourse

Critical pitfall: Do NOT perform surgery during active disease phase—surgical outcomes for patients with active disease are unknown 2

Surgical options by indication: 2

1. Tunical plication (most common, ~50% of PD surgeries):

   • Curvature improvement in ≥90% of cases
   • Results in some penile length loss
   • Best for patients with adequate penile length and preserved erectile function

2. Plaque incision/excision with grafting:

   • Curvature improvement ranging from 25-100%
   • Preserves penile length
   • Higher risk of erectile dysfunction

3. Penile prosthesis:

   • For patients with ED and/or penile deformity preventing coitus despite pharmacotherapy/vacuum therapy
   • Curvature improvement >80% in all reviewed studies
   • Use inflatable devices (NOT semi-rigid prostheses) to allow necessary modeling for optimal outcomes 2

---

Special Considerations for Your Patient Population

Risk Factors Present (Diabetes, Hypertension, Smoking, Prior Trauma)

• Higher prevalence: rates are elevated among men with comorbidities 1
• Erectile dysfunction: diabetes, hypertension, and smoking increase ED risk, which may complicate treatment selection and require combined management 1
• Prior penile trauma: microvascular trauma from penile buckling during sexual activity is the most common inciting event, though many patients don't recall specific incidents 1

Counseling Priorities

For some patients, thoughtful counseling regarding the nature of PD and typical disease course may be sufficient to alleviate concerns, and a patient may choose not to pursue further treatment. 1, 3

• Natural history: pain resolves over time without intervention in most patients; curvature is less likely to resolve, though younger men and those with symptoms <6 months may experience some improvement 1
• Psychological impact: address the significant emotional distress, depressive symptoms, and relationship difficulties that persist over time 1, 3
• Realistic expectations: discuss the likely magnitude of treatment effects and probability/type of adverse events to optimize effectiveness and patient satisfaction 1